Current Biotechnology publishes critical and authoritative reviews, original research and methodology articles, and thematic issues in all areas of biotechnology, including basic and applied research. The journal serves as an advanced forum for innovative studies and major trends at the interface of technology, life sciences and biomedicine. Our aim is to provide a comprehensive and reliable source of information on the current advances and future perspectives in key themes of biotechnology.
Articles from the journal Current Biotechnology 5 , Issue 4:
For details on the articles, please visit this link :: http://bit.ly/2fjyKt7
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
Articles from the journal Current Medicinal Chemistry 23, Issue 32:
For details on the articles, please visit this link :: http://bit.ly/2fyX2lm
XIX International Botanical Congress in 23-29 July, 2017 in Shenzhen China.
The International Botanical Congress (IBC) is a major convention that brings together scientists from around the world to discuss new research in the plant sciences. The IBC is held once every six years. The Congresses are particularly notable in that they not only bring together scientists from many countries, but also from many disciplines within the broader research fields related to the plant sciences, including botany, mycology, ecology, horticulture, agriculture, and other related fields. The increasing knowledge about plants—their history, growth, uses, interactions with other organisms, and roles in the ecosystem—is becoming progressively important for the stability and sustainability of the human endeavor and, indeed, of all life on Earth.
The XIX IBC will be held under the auspices of the International Union of Biological Sciences (IUBS), through the International Association of Botanical and Mycological Societies (IABMS) of the IUBS. The XIX IBC is organized by the Botanical Society of China and the Shenzhen Municipal Government. It will be held in the Shenzhen Convention and Exhibition Center, Shenzhen, China. The first circular will be sent in 2015 to all botanists and institutions through society mailings and upon request.
The XIX IBC has turned over a new leaf in the history of IBC with China being the first developing country to host the Congress. In addition to being a developing country, China is also a fast growing economy and one of the world’s biopersity hot spots. China’s successful experience in building an innovation-oriented society while protecting biopersity will help the Congress in the endeavor of achieving a sustainable earth.
Find more details here: http://www.ibc2017.cn/About/
Related eBook: http://ebooks.benthamscience.com/book/9781681080949/
Article by Disease on “HIV”
Background: It is well established that antiretroviral therapy (ART), while highly effective in controlling HIV replication, cannot eliminate virus from the body. Therefore, the majority of HIV-1-infected individuals remain at risk for developing AIDS due to persistence of infected reservoir cells serving as a source of virus re-emergence. Several reservoirs containing replication competent HIV-1 have been identified, most notably CD4+ T cells. Cells of the myeloid lineage, which are the first line of defense against pathogens and participate in HIV dissemination into sanctuary organs, also serve as cellular reservoirs of HIV-1. In latently infected resting CD4+ T cells, the integrated copies of proviral DNA remain in a dormant state, yet possess the ability to produce replication competent virus after cellular activation. Studies have demonstrated that modification of chromatin structure plays a role in establishing persistence, in part suggesting that latency is, controlled epigenetically.< p> Conclusion: Current efforts to eradicate HIV-1 from this cell population focus primarily on a “shock and kill” approach through cellular reactivation to trigger elimination of virus producing cells by cytolysis or host immune responses. However, studies revealed several limitations to this approach that require more investigation to assess its clinical application. Recent advances in gene editing technology prompted use of this approach for inactivating integrated proviral DNA in the genome of latently infected cells. This technology, which requires a detailed understanding of the viral genetics and robust delivery, may serve as a powerful strategy to eliminate the latent reservoir in the host leading to a sterile cure of AIDS.
Read more: http://benthamscience.com/journals/current-hiv-research/volume/14/issue/5/page/431/
Atta-ur-Rahman / Khurshid Zaman
This is the third volume of the Patent eBook Series entitled Topics in Anti-Cancer Research. This eBook comprises updated reviews on topics relevant to modern cancer research published in the journal Recent Patents on Anti-Cancer Drug Discovery.
The comprehensive range of themes covered in this third volume will be of benefit to clinicians, scientists and R&D experts looking for new targets for the prevention of cancer and discovery of drugs for the treatment of different cancer types. Regulation of tumor cells by TRAIL receptors, development of anti- cancer drugs & immunomodulatory drugs, molecular studies of adrenocortical cancer, role of inhibitors of inosine monophosphate dehydrogenase in cancer, recent updates in glioblastoma stem cells, latest approaches for cancer gene therapy and metabolic therapy for cancer were reviewed and updated. The role of pH regulation and application of hyperthermia, thiosemicarbazone derivatives, tamoxifen-based therapies for cancer treatment andproteome-based complex therapy of tumors, calcium signaling and angiogenesis, antineoplastic role of GHRH antagonists and therapeutic applications in human tumors and clinical oncology have been extensively discussed in the light of recent innovations.
The topics covered in this third volume will be valuable for those interested in scientists interests in methods for the prevention of cancer as well its management.
Read this insightful ebook here:
6th Asia-Pacific Breast Cancer Summit in Hong Kong 17-19 February 2017.
Being one of the most common cancers in women, both in developed and underdeveloped regions of the world, there is a need to discuss the latest aspects of breast cancer and its alarming increase. During the past five years, the Asia Pacific Breast Cancer Summit has been successfully addressing vital topics regarding this prevalent disease. In 2017, the 6th Asia Pacific Breast Cancer Summit once again aims to bring together international & regional faculty experts in breast cancer to cover surgical, radiation and medical oncology related topics on early and advanced breast cancer management.
Find more details here: http://www.breastsummit.org/index.php
Related eBook: Topics in Anti-Cancer Research